# Merlin Biomed: portfolio, investments and team > Merlin Biomed is a growth equity based in United States. 11 investments on record, latest Nov 2009. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/merlin-biomed (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Merlin Biomed No cheque observed since Nov 2009, after 11 earlier cheques, and the website is dead. Dormant Growth equity Series D Venture Series B Operating Systems Software Cheques on record **0%** of best year **0** **cheques in 12 months**, 11 on record Since the last cheque **6199** days **00** hrs **00** min **00** sec Median round **$32M** Rounds led **0 of 11** Exits **6 from the portfolio** Mostly in **United States, 82%** Pitch Merlin Biomed ## Merlin Biomed highlights - 01 11 rounds on record - 02 Mostly Series D and Venture: 73% of its rounds - 03 6 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Operating Systems Software - **Based in:** United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **11 appearances** - **2009** 1 round - **Nov** **[CymaBay Therapeutics](https://millionrounds.com/company/cymabay-therapeutics)** Venture · US · metabolex.com **$8.6M** With 11 others - **2008** 1 round - **Jul** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Series C · CA · siliconindia.com **$38M** With 12 others - **2007** 2 rounds - **Apr** **[CymaBay Therapeutics](https://millionrounds.com/company/cymabay-therapeutics)** Series D · US · metabolex.com **$32M** With 15 others - **Jan** **[Calypso Medical](https://millionrounds.com/company/calypso-medical)** Series D · US **$42M** With 7 others - **2006** 3 rounds - **Nov** **[EUSA Pharma](https://millionrounds.com/company/eusa-pharma)** Venture · GB **$19M** With 15 others - **Sept** **[RenaMed Biologics](https://millionrounds.com/company/renamed-biologics)** Venture · US · venturecapitalreporter.com **$40M** With 8 others - **Jun** **[Genelabs Technologies](https://millionrounds.com/company/genelabs-technologies)** Venture · US **$8.3M** With 4 others - **2005** 1 round - **Feb** **[FibroGen](https://millionrounds.com/company/fibrogen)** Series F · US · fibrogen.com **$100M** With 14 others - **2004** 1 round - **Jun** **[ARYx Therapeutics](https://millionrounds.com/company/aryx-therapeutics)** Series D · US **$55M** With 9 others - **2003** 2 rounds - **Oct** **[Salient Surgical Technologies](https://millionrounds.com/company/salient-surgical-technologies)** Series D · US **$30M** With 10 others - **Feb** **[BattellePharma](https://millionrounds.com/company/battellepharma)** Series B · US **$22M** With 4 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## Exits from the portfolio Companies it backed that were later bought or listed **6 in all** **[EUSA Pharma](https://millionrounds.com/company/eusa-pharma)** Bought by [Jazz Pharmaceuticals](https://millionrounds.com/fund/jazz-pharmaceuticals) **$650M** Apr 2012 **[Calypso Medical](https://millionrounds.com/company/calypso-medical)** Bought by Varian Medical Systems **Undisclosed** Sept 2011 **[Salient Surgical Technologies](https://millionrounds.com/company/salient-surgical-technologies)** Bought by [Medtronic](https://millionrounds.com/fund/medtronic) **$525M** Jul 2011 **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Bought by [Cephalon](https://millionrounds.com/fund/cephalon) **$525M** Mar 2011 **[Genelabs Technologies](https://millionrounds.com/company/genelabs-technologies)** Bought by [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) **$57M** Nov 2008 **[EUSA Pharma](https://millionrounds.com/company/eusa-pharma)** Bought by EUSA Pharma **$23M** Mar 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series D Venture Series B Median round joined **$32M** the round, not its cheque Led 0 of 11 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Nov 2009 - **Exits:** 6 from the portfolio Rounds by stage said on their site - Series D *4* - Venture *4* - Series B *1* - Series C *1* - Series F *1* Cheques by year Led Joined 2003 2009 Often in the room with - [VantagePoint Capital Partners](https://millionrounds.com/fund/vantagepoint-capital-partners) 3 - [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 3 - [Alta Partners](https://millionrounds.com/fund/alta-partners) 2 - [Apothecary Capital](https://millionrounds.com/fund/apothecary-capital) 2 - [Bay City Capital](https://millionrounds.com/fund/bay-city-capital) 2 - [Birchmere Ventures](https://millionrounds.com/fund/birchmere-ventures) 2 **Pitching Merlin Biomed?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Merlin Biomed. A count of rooms they were both in, not a relationship either has claimed. [**VantagePoint Capital Partners** VC firm **3** rounds together](https://millionrounds.com/fund/vantagepoint-capital-partners)[**Versant Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/versant-ventures)[**Alta Partners** VC firm **2** rounds together](https://millionrounds.com/fund/alta-partners)[**Apothecary Capital** VC firm **2** rounds together](https://millionrounds.com/fund/apothecary-capital)[**Bay City Capital** VC firm **2** rounds together](https://millionrounds.com/fund/bay-city-capital)[**Birchmere Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/birchmere-ventures)[**Fort Mason Capital** Investment firm **2** rounds together](https://millionrounds.com/fund/fort-mason-capital)[**KBC Private Equity** Private equity **2** rounds together](https://millionrounds.com/fund/kbc-private-equity)[**MPM Capital** Private equity **2** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**Novo Holdings** VC firm **2** rounds together](https://millionrounds.com/fund/novo-ventures)[**OrbiMed** Private equity **2** rounds together](https://millionrounds.com/fund/orbimed)[**Pictet Private Equity Investors S.A.** Growth equity **2** rounds together](https://millionrounds.com/fund/pictet-private-equity-investors-s-a) ## Quick answers about Merlin Biomed ### What does Merlin Biomed invest in? Merlin Biomed invests most often at Series D and Venture (73% of the rounds on record), in sectors such as Operating Systems and Software. ### How active is Merlin Biomed? 11 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2009. ### How big are Merlin Biomed's cheques? The median round it joins is $32M. ### Does Merlin Biomed lead rounds? Rarely, if at all: none of its 11 investments on record names it as the lead. ### Where does Merlin Biomed invest? Most of the companies it backs are in the United States (82%), Canada (9%) and the United Kingdom (9%). ### Is Merlin Biomed investing now? It looks quiet: no investment on record since Nov 2009. ### Who does Merlin Biomed invest alongside? Most often VantagePoint Capital Partners (3 rounds together), Versant Ventures (3 rounds together) and Alta Partners (2 rounds together). ### What kind of investor is Merlin Biomed? Merlin Biomed is a growth equity firm based in United States. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=merlin-biomed) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=merlin-biomed)